Disease-specific signature of serum miR-20b and its targets IL-8 and IL-25, in myasthenia gravis patients

European Cytokine Network

Volumn 26, Issue 3, 2015, Pages 61-66

  Chunjie, Nie ^a   Huijuan, Nie ^a   Zhao, Yin ^a   Jianzhao, Wu ^b   Xiaojian, Zhang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

IL 25; IL 8; MiRNA; Myasthenia gravis

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 25; INTERLEUKIN 8; MICRORNA 20B; PREDNISONE ACETATE; IL25 PROTEIN, HUMAN; INTERLEUKIN 17; MICRORNA; MIRN20 MICRORNA, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; MYASTHENIA GRAVIS; NERVE STIMULATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; BLOOD;

ADULT; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; MALE; MICRORNAS; MYASTHENIA GRAVIS;

EID: 84957566288     PISSN: 11485493     EISSN: 19524005     Source Type: Journal    
DOI: 10.1684/ecn.2015.0367     Document Type: Article

References (23)

1. Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: a review. Autoimmune Dis 2012; 2012: 874680.
2. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001; 357: 2122-8.
3. Drachman DB. Myasthenia gravis. New Eng J Med 1994; 330: 1797- 810.
4. Querol L, Illa I. Myasthenia gravis and the neuromuscular junction. Cur Opin Neurol 2013; 26: 459-65.
5. Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. J Neurol Sci 2004; 217: 131-3.
6. Berrih-Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoim 2014; 52: 90-100.
7. Kaminski HJ, Kusner LL, Wolfe GI, et al. Biomarker development for myasthenia gravis. An N Y Ac Sci 2012; 1275: 101-6.
8. Zampetaki A,Willeit P, Drozdov I, Kiechl S, MayrM.Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012; 93: 555-62.
9. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007; 17: 118-26.
10. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009; 32: 189-94.
11. Le Panse R, Berrih-Aknin S. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation. Cur Opin Neurol 2013; 26: 569-76.
12. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res 2011; 717: 85-90.
13. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483-95.
14. Barth D, Nabavi Nouri M, Ng E, Nwe P, Bril V. Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology 2011; 76: 2017-23.
15. Nogales-Gadea G, Ramos-Fransi A, Suarez-Calvet X, Navas M, Rojas-Garcia R, Mosquera JL, et al. Analysis of serum miRNA profiles of myasthenia gravis patients. PloS One 2014; 9: e91927.
16. Cheng Z, Qiu S, Jiang L, et al. MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1. J Clin Immunol 2013; 33: 567-76.
17. Punga T, Le Panse R, Andersson M, Truffault F, Berrih-Aknin S, Punga AR. Circulating miRNAs in myasthenia gravis: miR-150- 5p as a new potential biomarker. Ann Clin Transl Neurol 2014; 1: 49-58.
18. Kim TD, Lee SU, Yun S, et al. Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood 2011; 118: 5476-86.
19. Punga AR, Andersson M, Alimohammadi M, Punga T. Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients. J Neurol Sci 2015 Jun 14.
20. Jiang Z, Yin J, Fu W, et al. MiRNA 17 family regulates cisplatinresistant and metastasis by targeting TGFbetaR2 in NSCLC. PloS One 2014; 9: e94639.
21. Li D, Ilnytskyy Y, Kovalchuk A, et al. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer. Oncotarget 2013; 4: 1373-87.
22. Giraud-Triboult K, Rochon-Beaucourt C, Nissan X, Champon B, Aubert S, Pietu G. CombinedmRNAand microRNAprofiling reveals that miR-148a and miR-20b control human mesenchymal stem cell phenotype via EPAS1. Physiol Genomics 2011; 43: 77-86.
23. Zhu E, Wang X, Zheng B, et al. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORgammat and STAT3. J Immunol 2014; 192: 5599-609.